Differential effects of leptin receptor mutation on male and female BBDR.Gimap5-/Gimap5- spontaneously diabetic rats

Physiological Genomics

Volumn 41, Issue 1, 2010, Pages 9-20

  Moralejo, Daniel H ^a   Hansen, Carl T ^d   Treuting, Piper ^a   Hessner, Martin J ^e   Fuller, Jessica M ^a   Van Yserloo, Brian ^a   Jensen, Richard ^a   Osborne, William ^a,b   Kwitek, Anne E ^c   Lernmark, Åke ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diabetes; Islet inflammation; Lymphopenia; Obesity

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; LEPTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CELL COUNT; BODY WEIGHT; CELL DESTRUCTION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GIMAP5 GENE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERLEPTINEMIA; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LYMPHOCYTOPENIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SPLEEN; SURVIVAL RATE; THYMUS;

ADIPOKINES; ADIPOSITY; ANIMALS; ANIMALS, CONGENIC; BLOOD CELL COUNT; BLOOD GLUCOSE; BODY WEIGHT; BREEDING; CHROMOSOMES, MAMMALIAN; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GENOTYPE; GTP-BINDING PROTEINS; HYPERGLYCEMIA; MALE; MUTATION; OBESITY; PANCREAS; PHENOTYPE; RATS; RECEPTORS, LEPTIN; SEX CHARACTERISTICS; SURVIVAL ANALYSIS; TIME FACTORS;

RATTUS; RODENTIA;

EID: 77949660725     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00186.2009     Document Type: Article

References (52)

1. Bieg S, Koike G, Jiang J, Klaff L, Pettersson A, MacMurray AJ, Jacob HJ, Lander ES, Lernmark A. Genetic isolation of iddm 1 on chromosome 4 in the BioBreeding (BB) rat. Mamm Genome 9: 324-326, 1998.
2. Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, Gabay C. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168: 875-882, 2002.
3. Chua SC Jr, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271: 994-996, 1996.
4. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, Warram JH, Todd JA. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 40: 1399-1401, 2008.
5. Dalberg U, Markholst H, Hornum L. Both Gimap5 and the diabetogenic BBDP allele of Gimap5 induce apoptosis in T cells. Int Immunol 19: 447-453, 2007.
6. Dion C, Carter C, Hepburn L, Coadwell WJ, Morgan G, Graham M, Pugh N, Anderson G, Butcher GW, Miller JR. Expression of the Ian family of putative GTPases during T cell development and description of an Ian with three sets of GTP/GDP-binding motifs. Int Immunol 17: 1257-1268, 2005.
7. Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31: 1546-1549, 2008.
8. Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutr Rev 56: s38 -s46, 1998.
9. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
10. Fuller JM, Bogdani M, Tupling TD, Jensen RA, Pefley R, Manavi S, Cort L, Blankenhorn EP, Mordes JP, Lernmark A, Kwitek AE. Genetic dissection reveals diabetes loci proximal to the gimap5 lymphopenia gene. Physiol Genomics 38: 89-97, 2009.
11. Fuller JM, Kwitek AE, Hawkins TJ, Moralejo DH, Lu W, Tupling TD, Macmurray AJ, Borchardt G, Hasinoff M, Lernmark A. Introgression of F344 rat genomic DNA on BB rat chromosome 4 generates diabetes-resistant lymphopenic BB rats. Diabetes 55: 3351-3357, 2006.
12. Hellquist A, Zucchelli M, Kivinen K, Saarialho-Kere U, Koskenmies S, Widen E, Julkunen H, Wong A, Karjalainen-Lindsberg ML, Skoog T, Vendelin J, Cunninghame-Graham DS, Vyse TJ, Kere J, Lindgren CM. The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus. J Med Genet 44: 314-321, 2007.
13. Hessner MJ, Wang X, Meyer L, Geoffrey R, Jia S, Fuller J, Lernmark A, Ghosh S. Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat. J Immunol 173: 6993-7002, 2004.
14. Hornum L, Romer J, Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes 51: 1972-1979, 2002.
15. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 222: 19-26, 1996.
16. Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 24, Suppl: S317-S320, 1994.
17. Keita M, Leblanc C, Andrews D, Ramanathan S. GIMAP5 regulates mitochondrial integrity from a distinct subcellular compartment. Biochem Biophys Res Commun 361: 481-486, 2007.
18. Knip M, Reunanen A, Virtanen SM, Nuutinen M, Viikari J, Akerblom HK. Does the secular increase in body mass in children contribute to the increasing incidence of type 1 diabetes? Pediatr Diabetes 9: 46-49, 2008.
19. Koletsky S. Obese spontaneously hypertensive rats - a model for study of atherosclerosis. Exp Mol Pathol 19: 53-60, 1973.
20. Kupfer R, Lang J, Williams-Skipp C, Nelson M, Bellgrau D, Scheinman RI. Loss of a gimap/ian gene leads to activation of NF-kappaB through a MAPK-dependent pathway. Mol Immunol 44: 479-487, 2007.
21. La Cava A, Alviggi C, Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 82: 4-11, 2004.
22. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 12: 57-65, 1998.
23. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvationinduced immunosuppression. Nature 394: 897-901, 1998.
24. MacMurray AJ, Moralejo DH, Kwitek AE, Rutledge EA, Van Yserloo B, Gohlke P, Speros SJ, Snyder B, Schaefer J, Bieg S, Jiang J, Ettinger RA, Fuller J, Daniels TL, Pettersson A, Orlebeke K, Birren B, Jacob HJ, Lander ES, Lernmark A. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res 12: 1029-1039, 2002.
25. Markholst H, Eastman S, Wilson D, Andreasen BE, Lernmark A. Diabetes segregates as a single locus in crosses between inbred BB rats prone or resistant to diabetes. J Exp Med 174: 297-300, 1991.
26. Maruta K, Treichel U, Kolb-Bachofen V, Kolb H. Prospective analysis of eosinophilia in spontaneously diabetic BB rats: correlation with islet inflammation but not with diabetes development. Diabetes Res 11: 173-176, 1989.
27. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S. Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 166: 5909-5916, 2001.
28. Mattioli B, Straface E, Quaranta MG, Giordani L, Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 174: 6820-6828, 2005.
29. Meetoo D, McGovern P, Safadi R. An epidemiological overview of diabetes across the world. Br J Nurs 16: 1002-1007, 2007.
30. Michalkiewicz M, Michalkiewicz T, Ettinger RA, Rutledge EA, Fuller JM, Moralejo DH, Van Yserloo B, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A. Transgenic rescue demonstrates involvement of the Ian5 gene in T cell development in the rat. Physiol Genomics 19: 228-232, 2004.
31. Moralejo DH, Park HA, Speros SJ, MacMurray AJ, Kwitek AE, Jacob HJ, Lander ES, Lernmark A. Genetic dissection of lymphopenia from autoimmunity by introgression of mutated Ian5 gene onto the F344 rat. J Autoimmun 21: 315-324, 2003.
32. Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J 45: 278-291, 2004.
33. Mordes JP, Desemone J, Rossini AA. The BB rat. Diabetes Metab Rev 3: 725-750, 1987.
34. Moreno C, Dumas P, Kaldunski ML, Tonellato PJ, Greene AS, Roman RJ, Cheng Q, Wang Z, Jacob HJ, Cowley AW Jr. Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics 15: 243-257, 2003.
35. Nitta T, Takahama Y. The lymphocyte guard-IANs: regulation of lymphocyte survival by IAN/GIMAP family proteins. Trends Immunol 28: 58-65, 2007.
36. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 42: 1395-1403, 1999.
37. Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 176: 7745-7752, 2006.
38. Pihoker C, Scott CR, Lensing SY, Cradock MM, Smith J. Non-insulindependent diabetes mellitus in African-American youths of Arkansas. Clin Pediatr (Phila) 37: 97-102, 1998.
39. Resic-Lindehammer S, Larsson K, Ortqvist E, Carlsson A, Cederwall E, Cilio CM, Ivarsson SA, Jonsson BA, Larsson HE, Lynch K, Neiderud J, Nilsson A, Sjoblad S, Lernmark A, Aili M, Baath LE, Carlsson E, Edenwall H, Forsander G, Granstro BW, Gustavsson I, Hanas R, Hellenberg L, Hellgren H, Holmberg E, Hornell H, Johansson C, Jonsell G, Kockum K, Lindblad B, Lindh A, Ludvigsson J, Myrdal U, Segnestam K, Skogsberg L, Stromberg L, Stahle U, Thalme B, Tullus K, Tuvemo T, Wallensteen M, Westphal O, Aman J. Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol 45: 231-235, 2008.
40. Russell JC, Amy RM. Plasma lipids and other factors in the LA/N corpulent rat in the presence of chronic exercise and food restriction. Can J Physiol Pharmacol 64: 750-756, 1986.
41. Schranz DB, Lernmark A. Immunology in diabetes: an update. Diabetes Metab Rev 14: 3-29, 1998.
42. Scott J. The spontaneously diabetic BB rat: sites of the defects leading to autoimmunity and diabetes mellitus. Curr Top Microbiol Immunol 156: 1-14, 1990.
43. Siegel K, Narayan KV. The Unite for Diabetes campaign: overcoming constraints to find a global policy solution. Global Health 4: 3, 2008.
44. Siegmund B, Sennello JA, Jones-Carson J, Gamboni-Robertson F, Lehr HA, Batra A, Fedke I, Zeitz M, Fantuzzi G. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 53: 965-972, 2004.
45. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 14: 130-131, 1996.
46. Tartaglia LA. The leptin receptor. J Biol Chem 272: 6093-6096, 1997.
47. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271, 1995.
48. Tirabassi RS, Flanagan JF, Wu T, Kislauskis EH, Birckbichler PJ, Guberski DL. The BBZDR/Wor rat model for investigating the complications of Type 2 diabetes mellitus. ILAR J 45: 292-302, 2004.
49. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 1: 11-25, 2006.
50. Wilkin TJ. Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis. Pediatr Diabetes 9: 23-32, 2008.
51. Wu-Peng XS, Chua SC Jr, Okada N, Liu SM, Nicolson M, Leibel RL. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat. Diabetes 46: 513-518, 1997.
52. Yamashita T, Murakami T, Iida M, Kuwajima M, Shima K. Leptin receptor of Zucker fatty rat performs reduced signal transduction. Diabetes 46: 1077-1080, 1997.